{
  "DOI": "10.1038/s41431-019-0454-x",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/s41431-019-0454-x",
  "alternative-id": [
    "454"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "14 February 2018"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Revised",
      "name": "revised",
      "order": 2,
      "value": "17 May 2019"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 3,
      "value": "22 May 2019"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 4,
      "value": "21 June 2019"
    },
    {
      "group": {
        "label": "Compliance with ethical standards",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The authors declare that they have no conflict of interest."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Bank",
      "given": "Paul C. D.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Swen",
      "given": "Jesse J.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Schaap",
      "given": "Rowena D.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Klootwijk",
      "given": "Daniëlle B.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Baak – Pablo",
      "given": "Renée",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Guchelaar",
      "given": "Henk-Jan",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2019,
        6,
        21
      ]
    ],
    "date-time": "2019-06-21T18:10:39Z",
    "timestamp": 1561140639000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        20
      ]
    ],
    "date-time": "2023-05-20T21:00:09Z",
    "timestamp": 1684616409000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        5
      ]
    ],
    "date-time": "2024-04-05T05:17:13Z",
    "timestamp": 1712294233948
  },
  "is-referenced-by-count": 37,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "10",
  "issued": {
    "date-parts": [
      [
        2019,
        6,
        21
      ]
    ]
  },
  "journal-issue": {
    "issue": "10",
    "published-print": {
      "date-parts": [
        [
          2019,
          10
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2019,
            6,
            21
          ]
        ],
        "date-time": "2019-06-21T00:00:00Z",
        "timestamp": 1561075200000
      }
    },
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2019,
            6,
            21
          ]
        ],
        "date-time": "2019-06-21T00:00:00Z",
        "timestamp": 1561075200000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/s41431-019-0454-x.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/s41431-019-0454-x",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/s41431-019-0454-x.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "1532-1541",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2019,
        6,
        21
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2019,
        6,
        21
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2019,
        10
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1371/journal.pmed.0040209",
      "author": "JJ Swen",
      "doi-asserted-by": "publisher",
      "first-page": "e209",
      "journal-title": "PLoS Med",
      "key": "454_CR1",
      "unstructured": "Swen JJ, Huizinga TW, Gelderblom H, de Vries EG, Assendelft WJ, Kirchheiner J, et al. Translating pharmacogenomics: challenges on the road to the clinic. PLoS Med. 2007;4:e209.",
      "volume": "4",
      "year": "2007"
    },
    {
      "DOI": "10.1038/clpt.2010.279",
      "author": "MV Relling",
      "doi-asserted-by": "publisher",
      "first-page": "464",
      "journal-title": "Clin Pharmacol Ther",
      "key": "454_CR2",
      "unstructured": "Relling MV, Klein TE. CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network. Clin Pharmacol Ther. 2011;89:464–7.",
      "volume": "89",
      "year": "2011"
    },
    {
      "DOI": "10.1038/sj.clpt.6100507",
      "author": "JJ Swen",
      "doi-asserted-by": "publisher",
      "first-page": "781",
      "journal-title": "Clin Pharmacol Ther",
      "key": "454_CR3",
      "unstructured": "Swen JJ, Wilting I, de Goede AL, Grandia L, Mulder H, Touw DJ, et al. Pharmacogenetics: from bench to byte. Clin Pharmacol Ther. 2008;83:781–7.",
      "volume": "83",
      "year": "2008"
    },
    {
      "DOI": "10.1038/clpt.2011.34",
      "author": "JJ Swen",
      "doi-asserted-by": "publisher",
      "first-page": "662",
      "journal-title": "Clin Pharmacol Ther",
      "key": "454_CR4",
      "unstructured": "Swen JJ, Nijenhuis M, de Boer A, Grandia L, Maitland-van der Zee AH, Mulder H, et al. Pharmacogenetics: from bench to byte--an update of guidelines. Clin Pharmacol Ther. 2011;89:662–73.",
      "volume": "89",
      "year": "2011"
    },
    {
      "DOI": "10.1002/ajmg.c.31391",
      "author": "JM Hoffman",
      "doi-asserted-by": "publisher",
      "first-page": "45",
      "journal-title": "Am J Med Genet Part C Semin Med Genet",
      "key": "454_CR5",
      "unstructured": "Hoffman JM, Haidar CE, Wilkinson MR, Crews KR, Baker DK, Kornegay NM, et al. PG4KDS: a model for the clinical implementation of pre-emptive pharmacogenetics. Am J Med Genet Part C Semin Med Genet. 2014;166C:45–55.",
      "volume": "166C",
      "year": "2014"
    },
    {
      "DOI": "10.1038/clpt.2013.229",
      "author": "SL van Driest",
      "doi-asserted-by": "publisher",
      "first-page": "423",
      "journal-title": "Clin Pharmacol Ther",
      "key": "454_CR6",
      "unstructured": "van Driest SL, Shi Y, Bowton EA, Schildcrout JS, Peterson JF, Pulley J, et al. Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing. Clin Pharmacol Ther. 2014;95:423–31.",
      "volume": "95",
      "year": "2014"
    },
    {
      "DOI": "10.1038/clpt.2012.117",
      "author": "PH O’Donnell",
      "doi-asserted-by": "publisher",
      "first-page": "446",
      "journal-title": "Clin Pharmacol Ther",
      "key": "454_CR7",
      "unstructured": "O’Donnell PH, Bush A, Spitz J, Danahey K, Saner D, Das S, et al. The 1200 patients project: creating a new medical model system for clinical implementation of pharmacogenomics. Clin Pharmacol Ther. 2012;92:446–9.",
      "volume": "92",
      "year": "2012"
    },
    {
      "DOI": "10.1002/ajmg.c.31385",
      "author": "PH O’Donnell",
      "doi-asserted-by": "publisher",
      "first-page": "68",
      "journal-title": "Am J Med Genet Part C Semin Med Genet",
      "key": "454_CR8",
      "unstructured": "O’Donnell PH, Danahey K, Jacobs M, Wadhwa NR, Yuen S, Bush A, et al. Adoption of a clinical pharmacogenomics implementation program during outpatient care—initial results of the University of Chicago “1200 Patients Project”. Am J Med Genet Part C Semin Med Genet. 2014;166C:68–75.",
      "volume": "166C",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.mayocp.2013.10.021",
      "author": "SJ Bielinski",
      "doi-asserted-by": "publisher",
      "first-page": "25",
      "journal-title": "Mayo Clin Proc",
      "key": "454_CR9",
      "unstructured": "Bielinski SJ, Olson JE, Pathak J, Weinshilboum RM, Wang L, Lyke KJ, et al. Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol. Mayo Clin Proc. 2014;89:25–33.",
      "volume": "89",
      "year": "2014"
    },
    {
      "DOI": "10.2217/pgs.13.59",
      "author": "JA Johnson",
      "doi-asserted-by": "publisher",
      "first-page": "723",
      "journal-title": "Pharmacogenomics",
      "key": "454_CR10",
      "unstructured": "Johnson JA, Elsey AR, Clare-Salzler MJ, Nessl D, Conlon M, Nelson DR. Institutional profile: University of Florida and Shands Hospital Personalized Medicine Program: clinical implementation of pharmacogenetics. Pharmacogenomics. 2013;14:723–6.",
      "volume": "14",
      "year": "2013"
    },
    {
      "DOI": "10.1146/annurev-pharmtox-010814-124835",
      "author": "HM Dunnenberger",
      "doi-asserted-by": "publisher",
      "first-page": "89",
      "journal-title": "Annu Rev Pharm Toxicol",
      "key": "454_CR11",
      "unstructured": "Dunnenberger HM, Crews KR, Hoffman JM, Caudle KE, Broeckel U, Howard SC, et al. Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers. Annu Rev Pharm Toxicol. 2015;55:89–106.",
      "volume": "55",
      "year": "2015"
    },
    {
      "DOI": "10.2217/pgs-2016-0138",
      "author": "PC Bank",
      "doi-asserted-by": "publisher",
      "first-page": "215",
      "journal-title": "Pharmacogenomics",
      "key": "454_CR12",
      "unstructured": "Bank PC, Swen JJ, Guchelaar HJ. A nationwide survey of pharmacists’ perception of pharmacogenetics in the context of a clinical decision support system containing pharmacogenetics dosing recommendations. Pharmacogenomics. 2017;18:215–25.",
      "volume": "18",
      "year": "2017"
    },
    {
      "DOI": "10.1001/jama.2015.13766",
      "author": "ED Kantor",
      "doi-asserted-by": "publisher",
      "first-page": "1818",
      "issue": "17",
      "journal-title": "J Am Med Assoc",
      "key": "454_CR13",
      "unstructured": "Kantor ED, Rehm CD, Haas JS, Chan AT, Giovannucci EL. Trends in Prescription Drug Use Among Adults in the United States From 1999-2012. J Am Med Assoc. 2015;314(17):1818–31.",
      "volume": "314",
      "year": "2015"
    },
    {
      "DOI": "10.3111/13696998.2015.1110160",
      "author": "D Brixner",
      "doi-asserted-by": "publisher",
      "first-page": "213",
      "journal-title": "J Med Econ",
      "key": "454_CR14",
      "unstructured": "Brixner D, Biltaji E, Bress A, Unni S, Ye X, Mamiya T, et al. The effect of pharmacogenetic profiling with a clinical decision support tool on healthcare resource utilization and estimated costs in the elderly exposed to polypharmacy. J Med Econ. 2016;19:213–28.",
      "volume": "19",
      "year": "2016"
    },
    {
      "DOI": "10.1371/journal.pone.0170905",
      "author": "LS Elliott",
      "doi-asserted-by": "publisher",
      "first-page": "e0170905",
      "journal-title": "PLoS One",
      "key": "454_CR15",
      "unstructured": "Elliott LS, Henderson JC, Neradilek MB, Moyer NA, Ashcraft KC, Thirumaran RK. Clinical impact of pharmacogenetic profiling with a clinical decision support tool in polypharmacy home health patients: A prospective pilot randomized controlled trial. PLoS One. 2017;12:e0170905.",
      "volume": "12",
      "year": "2017"
    },
    {
      "author": "J Finkelstein",
      "first-page": "107",
      "journal-title": "Pharm Pers Med",
      "key": "454_CR16",
      "unstructured": "Finkelstein J, Friedman C, Hripcsak G, Cabrera M. Pharmacogenetic polymorphism as an independent risk factor for frequent hospitalizations in older adults with polypharmacy: a pilot study. Pharm Pers Med. 2016;9:107–16.",
      "volume": "9",
      "year": "2016"
    },
    {
      "DOI": "10.1186/s12888-017-1412-1",
      "author": "V Perez",
      "doi-asserted-by": "publisher",
      "journal-title": "BMC Psychiatry",
      "key": "454_CR17",
      "unstructured": "Perez V, Salavert A, Espadaler J, Tuson M, Saiz-Ruiz J, Saez-Navarro C, et al. Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial. BMC Psychiatry. 2017;17:250.",
      "volume": "17",
      "year": "2017"
    },
    {
      "DOI": "10.1007/s00228-011-1130-4",
      "author": "JJ Swen",
      "doi-asserted-by": "publisher",
      "first-page": "363",
      "journal-title": "Eur J Clin Pharmacol",
      "key": "454_CR18",
      "unstructured": "Swen JJ, van der Straaten T, Wessels JA, Bouvy ML, Vlassak EE, Assendelft WJ, et al. Feasibility of pharmacy-initiated pharmacogenetic screening for CYP2D6 and CYP2C19. Eur J Clin Pharmacol. 2012;68:363–70.",
      "volume": "68",
      "year": "2012"
    },
    {
      "DOI": "10.1007/s10549-015-3562-5",
      "author": "VO Dezentje",
      "doi-asserted-by": "publisher",
      "first-page": "583",
      "journal-title": "Breast Cancer Res Treat",
      "key": "454_CR19",
      "unstructured": "Dezentje VO, Opdam FL, Gelderblom H, Hartigh den J, Van der Straaten T, Vree R, et al. CYP2D6 genotype- and endoxifen-guided tamoxifen dose escalation increases endoxifen serum concentrations without increasing side effects. Breast Cancer Res Treat. 2015;153:583–90.",
      "volume": "153",
      "year": "2015"
    },
    {
      "DOI": "10.2217/pgs-2016-0013",
      "author": "CA Lunenburg",
      "doi-asserted-by": "publisher",
      "first-page": "721",
      "journal-title": "Pharmacogenomics",
      "key": "454_CR20",
      "unstructured": "Lunenburg CA, van Staveren MC, Gelderblom H, Guchelaar HJ, Swen JJ. Evaluation of clinical implementation of prospective DPYD genotyping in 5-fluorouracil- or capecitabine-treated patients. Pharmacogenomics. 2016;17:721–9.",
      "volume": "17",
      "year": "2016"
    },
    {
      "DOI": "10.1002/humu.21438",
      "author": "IF Fokkema",
      "doi-asserted-by": "publisher",
      "first-page": "557",
      "journal-title": "Hum Mutat",
      "key": "454_CR21",
      "unstructured": "Fokkema IF, Taschner PE, Schaafsma GC, Celli J, Laros JF, den Dunnen JT. LOVD v.2.0: the next generation in gene variant databases. Hum Mutat. 2011;32:557–63.",
      "volume": "32",
      "year": "2011"
    },
    {
      "DOI": "10.1038/ejhg.2013.118",
      "author": "DI Boomsma",
      "doi-asserted-by": "publisher",
      "first-page": "221",
      "journal-title": "Eur J Hum Genet: Ejhg",
      "key": "454_CR22",
      "unstructured": "Boomsma DI, Wijmenga C, Slagboom EP, Swertz MA, Karssen LC, Abdellaoui A, et al. The Genome of the Netherlands: design, and project goals. Eur J Hum Genet: Ejhg. 2014;22:221–7.",
      "volume": "22",
      "year": "2014"
    },
    {
      "DOI": "10.1038/ng.3021",
      "doi-asserted-by": "crossref",
      "key": "454_CR23",
      "unstructured": "Genome of the Netherlands Consortium. Whole-genome sequence variation, population structure and demographic history of the Dutch population. Nat Genet. 2014;46:818–25."
    },
    {
      "DOI": "10.1038/ng.3292",
      "author": "LC Francioli",
      "doi-asserted-by": "publisher",
      "first-page": "822",
      "journal-title": "Nat Genet",
      "key": "454_CR24",
      "unstructured": "Francioli LC, Polak PP, Koren A, Menelaou A, Chun S, Renkens I, et al. Genome-wide patterns and properties of de novo mutations in humans. Nat Genet. 2015;47:822–6.",
      "volume": "47",
      "year": "2015"
    },
    {
      "DOI": "10.1038/nature19057",
      "author": "M Lek",
      "doi-asserted-by": "publisher",
      "first-page": "285",
      "journal-title": "Nature",
      "key": "454_CR25",
      "unstructured": "Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285–91.",
      "volume": "536",
      "year": "2016"
    },
    {
      "DOI": "10.1002/cpt.602",
      "doi-asserted-by": "crossref",
      "key": "454_CR26",
      "unstructured": "van der Wouden CH, Cambon-Thomsen A, Cecchin E, Cheung KC, Lucia Davila-Fajardo C, Deneer VH, et al. Implementing pharmacogenomics in Europe: design and implementation strategy of the ubiquitous pharmacogenomics consortium. Clin Pharmacol Ther. 2017;101:341–58."
    },
    {
      "author": "SB Haga",
      "first-page": "197",
      "journal-title": "Pharm J",
      "key": "454_CR27",
      "unstructured": "Haga SB, O’Daniel JM, Tindall GM, Lipkus IR, Agans R. Survey of US public attitudes toward pharmacogenetic testing. Pharm J. 2012;12:197–204.",
      "volume": "12",
      "year": "2012"
    },
    {
      "DOI": "10.1159/000217795",
      "author": "J O’Daniel",
      "doi-asserted-by": "publisher",
      "first-page": "48",
      "journal-title": "Public Health Genom",
      "key": "454_CR28",
      "unstructured": "O’Daniel J, Lucas J, Deverka P, Ermentrout D, Silvey G, Lobach DF, et al. Factors influencing uptake of pharmacogenetic testing in a diverse patient population. Public Health Genom. 2010;13:48–54.",
      "volume": "13",
      "year": "2010"
    }
  ],
  "reference-count": 28,
  "references-count": 28,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/s41431-019-0454-x"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "A pilot study of the implementation of pharmacogenomic pharmacist initiated pre-emptive testing in primary care"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "27"
}